billiontoone responds to short seller report
BillionToOne (BLLN) responded to a short seller report by Fuzzy Panda Research, which holds a short position in the company. BLLN called the report inaccurate and misleading, defending its practices and disclosures. The company is reviewing legal options. BLLN develops molecular diagnostic tests and is headquartered in California.

